GLP-1drugs are hurting the snack food market. What does that mean for you?

The snack food market is currently facing negative impacts due to the increasing use of GLP-1 drugs among Americans. Medications such as Ozempic and Zepbound are being utilized for weight loss, which has resulted in a general reduction in calorie consumption. This trend is particularly evident within the processed foods and snack departments, as users of these specific GLP-1 treatments decrease their intake of these products to achieve their weight loss goals effectively.